Titer, Rate, and Yield

Titer, rate, and yield (TRY) are the fundamental metrics by which fermentation scientists evaluate and optimize bioprocesses. Titer measures the final concentration of product in the fermentation broth, directly impacting downstream processing costs since more dilute broths require more energy and materials to purify. Volumetric productivity (rate) determines how much product is made per unit volume per unit time, affecting capital utilization and facility throughput. Yield measures the efficiency of converting feedstock into product, which dominates raw material costs, the largest variable cost for many bio-based products.

Improving TRY metrics is the primary focus of strain engineering efforts at companies across the synthetic biology industry. Ginkgo Bioworks uses its biofoundry to systematically engineer strains for improved TRY through iterative design-build-test-learn cycles. Metabolic engineering strategies to improve these metrics include eliminating competing pathways to boost yield, optimizing expression levels to improve rate, and engineering tolerance mechanisms to enable higher product titers. Dynamic pathway regulation, where enzyme expression is modulated in response to cellular state, can balance growth and production phases to optimize overall TRY performance.

The target TRY values required for commercial viability depend heavily on the product's market value and application. High-value pharmaceuticals may be economically viable at titers below 1 g/L, while commodity chemicals typically require titers exceeding 50 to 100 g/L to compete with petrochemical production. A commonly cited benchmark for cost-competitive bio-based chemical production is a titer above 50 g/L, a rate above 2 g/L/h, and a yield above 50 percent of theoretical maximum. Achieving these targets simultaneously remains a major challenge that drives continued investment in strain engineering and fermentation optimization technologies.